Concept of dry weight in haemodialysis. Introduction   Achieving and maintaining dry-weight appears to be An effective but forgotten strategy in Controlling.

Slides:



Advertisements
Similar presentations
The ENCORE Study Cardiovascular Benefits Associated With the DASH Diet Alone and in Combination with Exercise and Weight Reduction in Men and Women with.
Advertisements

Cardiac Risk In ESRD Patient
M ETABOLIC S YNDROME IN P ERIONIAL D IALYSIS Dr. Sreelatha Calicut.
Joan Stadler, RDN Robert J. Dole VAMC  The heart does not pump normally so…  Blood backs into the lungs  Fluids back into the lungs  Insufficient.
Fluid & Electrolyte Imbalance
The FREEDOM Study (Impact of Short Daily Hemodialysis on Restless Legs Symptoms and Sleep Disturbances) Source Jaber BL, Schiller B, Burkart JM, et al.
How best to control salt overload in hypertension? - Dietetic? - Aligning dialysate sodium with patient's serum sodium -Prohibition of sodium profiling.
NxStage Kidney Care Encourage,Enhance,Empower Crystal Dean RN
EDWARD WELSH MARCH Dialysis Adequacy (?).
Overview of Profiling for Hemodialysis
Overview of Profiling for Hemodialysis
© 2007 Thomson - Wadsworth Chapter 13 Nutrition Care and Assessment.
JNC 8 Guidelines….
Profiling Ultrafiltration
Strategies for Improving Adequacy Decreasing the Risk of Premature Death Educate Your Dialysis Team Review Proper Procedure for Drawing Lab Samples - Lab.
HEMODIALYSIS ADEQUACY HEMODIALYSIS ADEQUACY Laurie Vinci RN, BSN, CNN Laurie Vinci RN, BSN, CNN September 17, 2011 September 17, 2011.
1 China Rural Health Initiative – Sodium Reduction Study: the effects of a community-based sodium reduction program on 24hr urinary sodium and blood pressure.
Hypertension. Hypertension or high blood pressure is a chronic medical condition in which the blood pressure in the arteries is elevated. This requires.
Ultrafiltration Control using Hematocrit Monitoring 2013 ANNA North Carolina Statewide Symposium and the Southeastern Kidney Council NC Annual Meeting.
Overcoming the challenge of blood pressure control in prediabetic and diabetic patients: PICASSO T2D Study Efficacy and tolerability of fixed dose combination.
Effect of Obesity on Kidney Transplantation Reference: Potluri K, Hou S. Obesity in kidney transplant recipients and candidates. Am J Kidney Dis. 2010;56:143–156.
Hypertension Assignment
Hypertension and Congestive Heart Failure Eugene Fong Cintia Aquino Alana Pearson.
BHS Guidelines for the management of hypertension BHS IV, 2004 and Update of the NICE Hypertension Guideline, 2006 Guidelines for management of hypertension:
Hypertension (high blood pressure) Dr. Fiona Gillan GP Registrar at Church End Medical Centre.
Hemoglobin A 1c in Hemodialysis Patients Source: Ix JH. Hemoglobin A1c in hemodialysis patients: Should one size fit all? Clin J Am Soc Nephrol. 2010;5:1539–1541.
Fluids and Electrolytes
Maximum home blood pressure: a novel indicator of target-organ damage in hypertension  Blood pressure variability has recently been shown to be a strong.
Diseases of the Renal System KNH 413. CKD - Renal Replacement Therapy Hemodialysis (HD) or Peritoneal Dialysis (PD) Type based on underlying kidney disease.
METABOLIC SYNDROME Dr Gerhard Coetzer. Complaint Thirsty all the time Urinating more than usual Blurred vision Tiredness.
HYPERTENSION The Alabama Department of Public Health’s Hypertension Program.
Systemic Hypertension. Systemic blood pressure measures 140/90 mm Hg or higher on at least two occasions a minimum of 1 to 2 weeks apart.
1 Hypertension Overview. 2 Leading Risks For Death (World Health Organization 2002) Cholesterol Alcohol HYPERTENSION Tobacco use Overweight.
VA/DoD 2006 Clinical Practice Guideline For Screening and Management of Overweight and Obesity Guideline Summary: Key Elements.
Blood pressure control in primary health care WORKSHOP
Thiazide-Like/Calcium Channel Blocker (CCB) Agents: A Major Combination for Hypertension Management Safar M, Blacher J. Am J Cardiovasc Drugs. 2014; DOI.
Blood Pressure Analysis among Sedentary and Moderately Active College Males Research Performed By Joseph Luncford Environmental Biology Tennessee Technological.
NS 210: Seminar 8 Nutritional Assessment in Disease Prevention.
HIGH BLOOD PRESSURE (HYPERTENSION) RAKAN ASSAF M. AL-ASSAF
CURRENT APPROACH TO THE TREATMENT OF CONGESTIVE HEART FAILURE.
PHARMACOLOGIC THERAPY  Standard First-Line Therapies Angiotensin-Converting Enzyme Inhibitors (ACEI) β Blockers Diuretics Digoxin  Second line Therapies.
HTN & CKD 1. HTN has been reported to occur in 85-95% of patients with CKD (stages 3–5). The relationship between HTN & CKD is cyclic in nature. Uncontrolled.
1 Profiling Conductivity. 2 Cellular Solute/Fluid Exchange Gambro Basics 1 (1994) All the membranes are semi-permeable allowing water to move freely between.
Monday, July 25 th,  Diagnostic Evaluation  COST  Confirm the diagnosis  Organize a diagnostic approach  Determine the Severity of the HTN.
NS 210: Seminar 8 Nutritional Assessment in Disease Prevention Leslie Young MS RD LDN.
Date of download: 6/24/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Year in Cardiovascular Surgery J Am Coll Cardiol.
Preemptive Kidney Transplant (PKT) – the Optimal Therapy in ESRD Reference: Connie L. Davis. Preemptive transplantation and the transplant first initiative.
Dr.M.shafiee Department of internal medicine Shiraz university of medical sciences.
HIGH BLOOD PRESSURE The Silent Killer
Intensive Hemodialysis: Applied Clinical Practice
Hypertension Hanna K. Al-Makhamreh, MD FACC Interventional Cardiology.
Treatment Thresholds and Non-Pharmacologic Therapy
Diseases of the Renal System
Achieving the Clinical Potential of RAAS Blockade
Cardiac Arrhythmias in Dialysis Patients
Hypertension in Dialysis Patients
Cardiac Arrhythmias in Dialysis Patients
Traditional parenteral antihypertensive treatment
Systolic Blood Pressure Intervention Trial (SPRINT)
Hypertension in Dialysis Patients
Section III: Neurohormonal strategies in heart failure
Figure 1 Changes in relative plasma volume (RPV)
Correlation between endothelial function and hypertension
Goals & Guidelines A summary of international guidelines for CHD
Dialysate Sodium: Choosing the Optimal Hemodialysis Bath
Diseases of the Renal System
Nutrition Care and Assessment
Role of sodium in hemodialysis
Diseases of the Renal System
Álvares et al. Am J Nephrol 2017;45: (DOI: / )
Presentation transcript:

Concept of dry weight in haemodialysis

Introduction   Achieving and maintaining dry-weight appears to be An effective but forgotten strategy in Controlling and maintaining normotension among hypertensive patients on hemodialysis Clin J Am Soc Nephrol ;5(7):

Introduction   The concept of dry-weight is as old as dialysis itself and has been defined various ways and evolved over time   In 1967, Dry-weight was initially defined by Thomson and colleagues as Reduction of BP to hypotensive levels during ultrafiltration and unassociated with other obvious causes Clin J Am Soc Nephrol ;5(7):

Dry-weight: Definition   In 1980, Henderson defined as The weight obtained at the conclusion of a regular dialysis treatment below which the patient more often than not will become symptomatic and go into shock   In 1996, Charra and colleagues defined as Body weight at the end of dialysis at which the patient can remain normotensive until the next dialysis despite the retention of saline and ideally without the use of antihypertensive medications Clin J Am Soc Nephrol ;5(7):

Dry-weight: Definition   In 2008, Raimann et al. proposed a definition of dry-weight defined by Continuous calf bioimpedance analysis during dialysis They defined dry-weight as a flattening of the baseline/instantaneous impedance ratio curve for at least 20 minutes in the presence of ongoing ultrafiltration Clin J Am Soc Nephrol ;5(7):

Dry-weight: Definition   Finally, in 2009, Sinha and Agarwal proposed a definition that Combines subjective and objective measurements   According to this recent definition, Dry-weight is defined as the lowest tolerated postdialysis weight achieved via gradual change in postdialysis weight at which there are minimal signs or symptoms of hypovolemia or hypervolemia Clin J Am Soc Nephrol ;5(7):

Dry-weight   Dry-weight and sodium Because excess dietary or dialysate sodium may provoke excess interdialytic weight gain, clinicians often confuse that a strong link exists between salt and dry-weight Notably, none of the definitions of dry-weight include dietary or dialysate sodium measurements Clin J Am Soc Nephrol ;5(7):

Dry-Weight: Assessment   Pedal edema does not correlate with dry- weight very well   For most part, the assessment and achievement of dry-weight is an iterative process that often provokes uncomfortable intradialytic symptoms such as hypotension, dizziness, cramps, nausea, and vomiting Clin J Am Soc Nephrol ;5(7):

Dry-Weight: Assessment   The symptoms lead to interventions such as Cessation of ultrafiltration, administration of saline, the premature cessation of dialysis, or placing the patient in the head-down (Trendelenburg) position.   Interestingly, placing the patient in the Trendelenburg position does little to protect the BP, and this practice is questionable. however,   Raising the leg passively without lowering the head can be effective for raising ventricular filling pressure Clin J Am Soc Nephrol ;5(7):

Dry-Weight: Assessment  Newer developments   Relative plasma volume (RPV) monitoring Utilizes photooptical technology to noninvasively measure absolute hematocrit through a transparent chamber affixed to the arterial end of the dialyzer   Body impedance analysis   Portable mass spectrometers (total body water) Clin J Am Soc Nephrol ;5(7):

Dry-Weight: Benefits of assessment   Among hemodialysis patients, Dry-weight reduction is an effective strategy for reducing BP   The center using dry-weight and salt restriction as a strategy had the following benefits: Lower antihypertensive drug use (7% versus 42%), Lower interdialytic weight gain, Lower left ventricular mass, better diastolic and systolic left ventricular function, and fewer episodes of intradialytic hypotension Clin J Am Soc Nephrol ;5(7):

Dry-Weight: Benefits of assessment   The results suggest that Probing for dry-weight as opposed to adding more antihypertensive drugs perhaps diminishes the risk for cardiac remodeling Although, a crosssectional study cannot assert causation, the results of this study Support the use of nonpharmacologic therapies in the management of patients with ESRD Clin J Am Soc Nephrol ;5(7):

Dry-Weight: Barriers to the Achievement  Nonadherence with Prescription Patients often miss dialysis or want to reduce their time on dialysis This may be a significant but often overlooked factor that limits the achievement of dry- weight   Too Short Dialysis Short-duration dialysis may limit the achievement of dry-weight Clin J Am Soc Nephrol ;5(7):

Dry-Weight: Barriers to the Achievement  Excess Dietary Sodium Monitoring interdialytic weight gain serves as a convenient tool to monitor dietary salt intake The management of patients with ESRD requires counseling to limit dietary salt intake when weight gain becomes excessive Patients with ESRD may have salt craving and may therefore consume excess salt Clin J Am Soc Nephrol ;5(7):

Dry-Weight: Barriers to the Achievement  Dialysate Sodium Excess High dialysate sodium improve hemodynamic stability but may aggravate interdialytic hypertension A simple strategy to limit sodium exposure is to reduce dialysate sodium In some patients, low sodium dialysate prescription may aggravate intradialytic hypotension Reducing the dialysate temperature to 35°C may help sustain intradialytic BP in such patients. Clin J Am Soc Nephrol ;5(7):

Conclusions   Dietary or dialysate sodium intake is a modifiable risk factor that can lead to better BP control However, dietary sodium restriction requires lifestyle modifications that are difficult to implement and even harder to sustain over the long term   Restricting dialysate sodium is a simpler but Underexplored strategy that can Reduce thirst, limit interdialytic weight gain, and assist the achievement of dry-weight

Conclusions   Dry-weight can be assessed Inexpensively through RPV monitoring and body impedance analysis   Achievement of dry-weight can Improve interdialytic BP, reduce pulse pressure, and limit hospitalizations   Probing dry-weight among patients with ESRD has the potential to Improve dismal cardiovascular outcomes through reducing cardiac pressure/volume load and limit remodeling

Conclusions   Thus, medication-directed approaches for BP control should be a secondary consideration to manipulating the diet and dialysis prescription to achieve dry-weight   Dialysis technicians can do a great job in achieving this goal